Leukotriene D4-d5

Leukotriene D4-d5 Struktur
1240398-17-7
CAS-Nr.
1240398-17-7
Englisch Name:
Leukotriene D4-d5
Synonyma:
Leukotriene D4-d5;YEESKJGWJFYOOK-HXHZKDJLSA-N
CBNumber:
CB62591591
Summenformel:
C25H40N2O6S
Molgewicht:
496.66
MOL-Datei:
1240398-17-7.mol

Leukotriene D4-d5 Eigenschaften

storage temp. 
Store at -80°C
Löslichkeit
DMF: 50 mg/ml,DMSO: 50 mg/ml,Ethanol: 1 mg/ml,PBS (pH 7.2): .1 mg/ml

Sicherheit

Leukotriene D4-d5 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Leukotriene D4-d5 (LTD4-d5) is intended for use as an internal standard for the quantification of LTD4 by GC- or LC-MS. LTD4 is an active metabolite of LTC4 (Item Nos. 20210 | 10007241) and a constituent of slow-reacting substance of anaphylaxis (SRS-A). It is formed via metabolism of LTC4 by γ-glutamyl transpeptidase. Like LTC4, LTD4 (0.01-0.1 pM) induces contractions in isolated guinea pig parenchymal strips and tracheal spirals. In vivo, LTD4 increases insufflation pressure, a marker of bronchoconstriction, in anesthetized guinea pigs by 100% when administered at a dose of 89 pmol per animal. It also increases vascular permeability in guinea pig skin when administered intradermally at a dose of 0.1 pmol per animal.

Leukotriene D4-d5 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Leukotriene D4-d5 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11289 58
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44894 58
amyjetsci 027-59626688 18771149750
sales@amyjet.com China 3004 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 8740 58
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826
market@aladdin-e.com China 48467 58

  • Leukotriene D4-d5
  • YEESKJGWJFYOOK-HXHZKDJLSA-N
  • 1240398-17-7
Copyright 2019 © ChemicalBook. All rights reserved